title: [Individualized treatment of osteoporosis].
abstract: Osteoporosis is the most common clinical disorder of bone metabolism. Treatment decisions should be made on an individual basis, taking into consideration the relative benefits and risks in different patient populations. Drug selection should be based on the form (primary/secondary) and severity of osteoporosis, age, sex, the specific contraindications and precautions for using the various available medications, and existing comorbidities.
authors.affiliation: Medizinische Klinik 1, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. birgit.harbeck@uksh.de.
authors.forename: B
authors.initials: B
authors.lastname: Harbeck
authors.affiliation: Präsidium, Universität zu Lübeck, Lübeck, Deutschland.
authors.forename: H
authors.initials: H
authors.lastname: Lehnert
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D000066491:Clinical Decision-Making / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control*; D018802:Patient-Centered Care / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents
keywords: Age factors; Comorbidity; Fracture prophylaxis; Osteoporosis, drug therapy; Risk assessment